These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 15901795

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Therapeutically relevant plasma concentrations of memantine produce significant L-N-methyl-D-aspartate receptor occupation and do not impair learning in rats.
    Morè L, Gravius A, Nagel J, Valastro B, Greco S, Danysz W.
    Behav Pharmacol; 2008 Oct; 19(7):724-34. PubMed ID: 18797249
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Noncompetitive NMDA receptor antagonists with fast open-channel blocking kinetics and strong voltage-dependency as potential therapeutic agents for Alzheimer's dementia.
    Müller WE, Mutschler E, Riederer P.
    Pharmacopsychiatry; 1995 Jul; 28(4):113-24. PubMed ID: 7491365
    [Abstract] [Full Text] [Related]

  • 51. Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation.
    Song MS, Rauw G, Baker GB, Kar S.
    Eur J Neurosci; 2008 Nov; 28(10):1989-2002. PubMed ID: 19046381
    [Abstract] [Full Text] [Related]

  • 52. Design of antagonists for NMDA and AMPA receptors.
    Bolshakov KV, Kim KH, Potapjeva NN, Gmiro VE, Tikhonov DB, Usherwood PN, Mellor IR, Magazanik LG.
    Neuropharmacology; 2005 Aug; 49(2):144-55. PubMed ID: 15996563
    [Abstract] [Full Text] [Related]

  • 53. Probing N-methyl-D-aspartate receptor desensitization with the substituted-cysteine accessibility method.
    Thomas CG, Krupp JJ, Bagley EE, Bauzon R, Heinemann SF, Vissel B, Westbrook GL.
    Mol Pharmacol; 2006 Apr; 69(4):1296-303. PubMed ID: 16377766
    [Abstract] [Full Text] [Related]

  • 54. Experimental glutamatergic excitotoxicity in rabbit retinal ganglion cells: block by memantine.
    Hare WA, Wheeler L.
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2940-8. PubMed ID: 19136701
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. N-methyl-D-aspartate receptor antagonists for migraine: a potential therapeutic approach.
    Ye R, Kong X, Han J, Zhao G.
    Med Hypotheses; 2009 May; 72(5):603-5. PubMed ID: 19168292
    [Abstract] [Full Text] [Related]

  • 57. Different effects of two N-methyl-D-aspartate receptor antagonists on seizures, spontaneous behavior, and motor performance in immature rats.
    Mares P, Mikulecká A.
    Epilepsy Behav; 2009 Jan; 14(1):32-9. PubMed ID: 18786655
    [Abstract] [Full Text] [Related]

  • 58. Neuroprotection by tosyl-polyamine derivatives through the inhibition of ionotropic glutamate receptors.
    Masuko T, Namiki R, Nemoto Y, Miyake M, Kizawa Y, Suzuki T, Kashiwagi K, Igarashi K, Kusama T.
    J Pharmacol Exp Ther; 2009 Nov; 331(2):522-30. PubMed ID: 19644042
    [Abstract] [Full Text] [Related]

  • 59. Subtype-dependence of N-methyl-D-aspartate receptor modulation by pregnenolone sulfate.
    Horak M, Vlcek K, Chodounska H, Vyklicky L.
    Neuroscience; 2006 Nov; 137(1):93-102. PubMed ID: 16257494
    [Abstract] [Full Text] [Related]

  • 60. Memantine binding to a superficial site on NMDA receptors contributes to partial trapping.
    Kotermanski SE, Wood JT, Johnson JW.
    J Physiol; 2009 Oct 01; 587(Pt 19):4589-604. PubMed ID: 19687120
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.